Delivery Order SPE2DB22D9244-SPE2DB25FZS65
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency on September 15, 2025, for Xolair 300 mg/2 ml auto-injector pharmaceutical products, with a ceiling value of $1,712.23. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,424.46 by the Defense Logistics Agency on September 11, 2025, for the supply of Xolair 300 mg/2 mL auto-injector units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, and no set-aside designation was applied to this procurement action. This delivery order is issued under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,277.01 by the Defense Logistics Agency (DLA) on June 18, 2025, with an ultimate completion date of July 11, 2025. The contract covers the supply of Xolair 75 mg/0.5 ml auto-injector units and is structured as a firm fixed-price delivery order with no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $13,697.84 by the Defense Logistics Agency on April 24, 2025, for the supply of Xolair 300 mg/2 ml auto-injector medications. The delivery order, which carries no set-aside designation, is scheduled for completion by May 15, 2025, with performance occurring at the company's Park Ridge facility. This award represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,424.44 by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of XOLAIR 150 mg/ml autoinjector medication. The contract carries a firm fixed-price structure with an ultimate completion date of August 28, 2025, and was awarded without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $10,273.38 by the Defense Logistics Agency on August 26, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. The contract carries no set-aside designation and is scheduled for completion by September 17, 2025, with performance taking place at the contractor's Park Ridge facility. This delivery order is issued...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,424.46 by the Defense Logistics Agency on April 24, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. The award utilizes a firm fixed-price contract type with no set-aside designation, with an ultimate completion date of May 15, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $28.3K by the Defense Logistics Agency's Medical Supply Chain on August 27, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order is scheduled for completion by September 18, 2025, with no set-aside designation applied. The award represents a discrete fulfillment under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,424.46 by the Defense Logistics Agency on August 19, 2025. The contract calls for the delivery of Xolair 300 mg/2 ml auto-injector vials, a biologic medication used primarily for severe asthma and other allergic conditions. This delivery order was issued without a set-aside designation, and performance is scheduled for...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $1,712.23 by the Defense Logistics Agency (DLA) for the supply of Xolair 300 mg/2 ml auto-injector vials. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award...
- SPE2DB22D9244Indefinite Delivery Contract
- SPE2DB22D9244-SPE2DB25FZS65Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 26, 2025, by the Defense Logistics Agency for Xolair 300 mg/2 ml auto-injector medications. The contract is valued at $1,712.23 with a firm fixed-price structure and no set-aside designation. The delivery order is set to be completed by September 17, 2025, and represents a single purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and extending through November 2026. This delivery order exemplifies DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply chain, particularly for the Department of Defense healthcare system. The company leverages its standing Indefinite Delivery Contract under the SPE2DB program to fulfill specialized pharmaceutical needs for military health facilities. Xolair, an autoinjector medication used in treating allergic and immunological conditions, will be delivered to the Place of Performance in Park Ridge, Illinois. The award demonstrates the company's consistent ability to secure contracts for a diverse portfolio of pharmaceutical products ranging from prescription medications to biologics and specialty treatments that support military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/26/25 |